SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Thursday reported earnings of $229.9 million in its second quarter.

On a per-share basis, the San Diego-based company said it had net income of $1.90. Earnings, adjusted for one-time gains and costs, were $2.28 per share.

The biopharmaceutical company posted revenue of $481 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $409.6 million.

Halozyme Therapeutics expects full-year earnings in the range of $8.65 to $9 per share, with revenue in the range of $1.84 billion to $1.91 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO